Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. has appointed Ms. Wang Lei as the new Chairman of the Board and Mr. Xing Jianhua as a Director. These leadership changes were decided at the company’s 9th Board meeting for the fiscal year 2024, reflecting the company’s strategic direction and governance.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.